مواقع التدريسيينجامعة الكوفة
منار حميد محمد جواد الشيخ راضي
مدرس

منار حميد محمد جواد الشيخ راضي

English Version
0بحث منشور
0محاضرة
0خبر

الملف الشخصي

حاصلة على شهادة البكالوريوس في العلوم الصيدلانية من كلية الصيدلة /جامعة بغداد سنة 2006؛ شهادة الماجستير في الادوية والعلاجيات من كلية الطب / جامعة الكوفة سنة 2019؛ شهادة الدكتوراه في علوم الصيدلة من كلية الصيدلة / جامعة الكوفة ، سنة 2025 ، تدريسية في كلية طب الصيدلة/ فرع الصيدلة السريرية

البحوث المنشورة

6
2025

Silibinin nephroprotective effects in renal ischemia reperfusion injury in rats via regulation of Notch-1

الباحثونManar H. Mohammed، Fadhel J. Rizij2
المجلةWiadomości Lekarskie Medical Advances
التاريخ2025-11-01
مختصر البحث

Aim: To evaluate nephroprotective effects of Silibinin in renal ischemia -reperfusion injury in rats by regulation of Notch-1 and Jagged-1. Materials and Methods: 28 male Wistar albino rats were randomly divided into four groups, (seven rats / group): sham group (laparotomy only), control group (ischemia for 30 min / 2 hrs reperfusion), DMSO vehicle group (rats were injected intraperitoneally with 10% DMSO 1 hour before ischemia, then ischemia for 30 min / 2 hrs reperfusion, Silibinin treatment group (rats were injected with Silibinin (60 mg/kg) intraperitoneally 1 hour before ischemia, then “ischemia for 30 min / 2 hrs reperfusion. The kidneys were harvested after 2 hours of reperfusion for assessment of kidney injury molecule-1 (KIM-1), interleukin 1 β (IL-1β), TNF-α, F2-Isoprostane, and glutathione (GSH) by ELISA technique; Notch-1 and Jagged-1 mRNA levels were assessed by reverse transcription-polymerase chain reaction (RT-PCR), BAX and Bcl2 protein expression were assessed by immunohistochemistry (IHC). Results: Silibinin demonstrated considerable amelioration of renal ischemia reperfusion injury as evidenced by the significant reduction of KIM-1, IL-1β, TNF α, F2-Isoprostane, in rat kidneys pretreated with Silibinin, GSH level was significantly elevated in rat kidneys pretreated with silibinin. Furthermore silibinin pretreatment significantly reduced Notch-1 and Jagged-1 mRNA expression after renal ischemia reperfusion. Conclusions: Silibinin offers protection against renal ischemia reperfusion injury due to its antioxidant, anti-inflammatory, and anti-apoptotic effects, those effects are associated with the downregulation of Notch-1 and its ligand, Jagged-

2020

MYRICETIN AMELIORATES BRAIN DAMAGE INDUCES BY CEREBRAL ISCHEMIA-REPERFUSION INJURY IN RATS

الباحثونManar Hameed Mohammed، Fadhaa Abdulameer Ghafil Wadhah Mahbuba Laith M Abbas Al-Huseini Maysaa Ali Abdul Khaleq Zina Zwaini Najah R Hadi
المجلة Asian Journal of Pharmaceutics (AJp
مختصر البحث

Background: Interruption of blood flow may result in considerable tissue damage via ischemia/ reperfusion injury induced oxidative stress in brain tissues. The present study aimed to investigate the effects of myricetin treatment in rats cerebral I/R injury. Material and Methods: The study was carried out on 36 Wistar-albino rats, divided into four groups including Sham group, I/R group, I/R+(control-vehicle DMSO) and I/R+ myricetin 50 mg/kg intraperitoneally 1 hour before induction of ischemia. Measurement of brain tissue IL-1β, ICAM- 1, caspase-3, Notch 1 and jagged 1 was done after one hour of reperfusion with assessment of the brain infarcted area and histopathological analysis. Results: Myricetin attenuates the cerebral I/R injury induced increase in inflammatory cytokine (IL-1β), adhesion molecule (ICAM-1) and proapoptotic enzyme (caspase-3). Additionally, it reduces the size of infarcted area and histopathological damage. However, such protective effect was not found to be mediated by Notch 1 pathway because myricetin treatment didn’t show changes in the increased levels of Notch 1 and Jagged 1 seen in brain with I/R injury. Conclusions: Myricetin has a neurocytoprotective effect against cerebral I/R injury which is manifested as anti-inflammatory anti-apoptotic preserving cell structure and viability, nevertheless this effect is not mediated through Notch 1 pathway.

2023

USE OF INFLIXIMAB TO ATTENUATE CEREBRAL APOPTOSIS INDUCED BY CEREBRAL ISCHEMIA/REPERFUSION IN MALE RATS

الباحثونSaif M. Hassan1، , Manar Hameed Mohammed2 , Mahmood J. Jawad1 , Ashwaq Najemaldeen Abbas3
المجلةWiadomości Lekarskie Medical Advances
التاريخ2023-02-02
مختصر البحث

The aim: The purpose of the research was to study the role of infliximab global cerebral ischemia-reperfusion injury. Materials and methods: The rats were split into five groups: Sham group; Control group: occlusion of the common carotid artery for 60 minutes, and subsequently reperfusion for an hour without receiving any medication; Vehicle group: as the control group, but 72 hours before to the ischemia, they were given the medication 0.9 NaCl intraperitoneally (i.p); Treated group-1: as the control group, plus 3 mg/kg of IFX intraperitoneally (i.p) 72 hours prior to ischemia; Treated group-2: as the control group, plus 7 mg/kg of IFX intraperitoneally (i.p) 72 hours prior to ischemia. Results: Pre-treatment with IFX significantly reduced the percentage of infarct area, but in the IFX (7 mg/kg) group, the infarct area was smaller than at the low dose. The ischemia group had a significant elevated of TNF-α and caspase-3 while a significant lowered in CAT and SOD levels. The pre-treatment with IFX, the TNF-α and caspase-3 levels lowered significantly, furthermore, significantly increased CAT and SOD levels activity (P≤0.05) as compared with IR group. Among effective groups, I/R+IFX (7mg/kg) group more effective in lowering TNF-α and caspase than I/R+IFX (3mg/kg) group. Conclusions: Infliximab has neuroprotective effective due to its powerful TNF-α blocker and limit ROS release and cell death signaling which protects the neurons from injury during cerebral ischemia reperfusion.

2023

Role of dimethyl fumarate (Nrf2 activator) in reducing of ciprofloxacin-induced hepatotoxicity in rats via the Nrf2/Ho-1 pathway

الباحثونMahmood Jawad1، , Karam Al-Akkam2 , Manar Mohammed3 , Saif M. Hassan
المجلةWiadomości Lekarskie Medical Advances
التاريخ2023-05-01
مختصر البحث

ABSTRACT The aim: The present study aims to study the effect of DMF on ciprofloxacin-induced liver damage as assessed by liver function and liver pathology and to study this effect if it is thought to activate the Nrf2 antioxidant defense mechanism. Materials and methods: G1 (control), G2 (ciprofloxacin group), G3 and G4 (two DMF groups rats treated with DMF 50mg and 100mg), and G5 and G6 (two DMF groups rats treated with DMF 50mg and 100mg) (two ciprofloxacin Plus DMF at 50 mg and 100 mg). The tests included study of liver function, Nrf2 analysis, and anti-oxidant enzyme analysis. Results: The serum blood Nrf2, HO-1, and tissue anti-oxidant enzymes all increased after ciprofloxacin treatment. The serum levels of Nrf2 and HO-1 were higher in the ciprofloxacin plus DMF groups, but anti-oxidant enzymes were lower. DMF increased Nrf2 expression in rats when ciprofloxacin caused hepatotoxicity. Conclusions: DMF lowers experimental hepatotoxicity in vivo. This effect is thought to activate the Nrf2 antioxidant defense mechanism

2023

Role of dimethyl fumarate (Nrf2 activator) in reducing of ciprofloxacin-induced hepatotoxicity in rats via the Nrf2/Ho-1 pathway

الباحثونMahmood Jawad1، , Karam Al-Akkam2 , Manar Mohammed3 , Saif M. Hassan
المجلةWiadomości Lekarskie Medical Advances
التاريخ2023-05-01
مختصر البحث

ABSTRACT The aim: The present study aims to study the effect of DMF on ciprofloxacin-induced liver damage as assessed by liver function and liver pathology and to study this effect if it is thought to activate the Nrf2 antioxidant defense mechanism. Materials and methods: G1 (control), G2 (ciprofloxacin group), G3 and G4 (two DMF groups rats treated with DMF 50mg and 100mg), and G5 and G6 (two DMF groups rats treated with DMF 50mg and 100mg) (two ciprofloxacin Plus DMF at 50 mg and 100 mg). The tests included study of liver function, Nrf2 analysis, and anti-oxidant enzyme analysis. Results: The serum blood Nrf2, HO-1, and tissue anti-oxidant enzymes all increased after ciprofloxacin treatment. The serum levels of Nrf2 and HO-1 were higher in the ciprofloxacin plus DMF groups, but anti-oxidant enzymes were lower. DMF increased Nrf2 expression in rats when ciprofloxacin caused hepatotoxicity. Conclusions: DMF lowers experimental hepatotoxicity in vivo. This effect is thought to activate the Nrf2 antioxidant defense mechanism

2022

PRETREATMENT WITH ERYTHROPOIETIN ALLEVIATES THE RENAL DAMAGE INDUCED BY ISCHEMIA REPERFUSION VIA REPRESSION OF INFLAMMATORY RESPONSE

الباحثونThu-Alfeqar R. Tweij1 ، Maryam A. Al-Issa2 , Manar Hamed1 , Maysaa Ali Abdul Khaleq3 , Abdullah Jasim4 , Najah R. Hadi5
المجلةwiadomości lekarskie medical advances
التاريخ2022-12-01
مختصر البحث

The aim: This study aimed to examine the anti-inflammatory, and antiapoptotic effects of erythropoietin against kidney injury inducted by ischemia reperfusion in experimental model. Materials and methods: 20 male Sprague Dawley rats were randomly divided into 4 equal groups: sham (subject to median laparotomy only), control (subject to 30 minutes ischemia and 2hours reperfusion), vehicle (injected by distilled water and subjected to the same procedure of ischemia reperfusion), erythropoietin group (as in vehicle group but the rats pretreated with 1000 U/kg of erythropoietin). The left kidney and blood specimen were collected. The blood utilized to assess serum creatinine. While kidneys utilized to assessed MCP-1, TLR2, and caspase-3 in addition to histopathological evaluation. Results: Control and vehicle samples showed that a significant elevation in serum creatinine, TLR2, caspase-3, and MCP-1 as compared with sham group. The histological evaluation showed a significant rise in kidney injury scores. Kidneys and blood samples of erythropoietin pretreated rats established histopathological and functional improvement as evidenced via reduced kidney injury scores in addition to the reduction in serum creatinine, as well as there were a significant diminished in caspase-3, MCP-1, and TLR2 levels when compared with control and vehicle groups. Conclusions: Erythropoietin has renoprotective effect against ischemia and reperfusion, which achieved by decrease the inflammatory response as well as antiapoptotic effect

المحاضرات

9

pharmacokinetics

pharmacology

pharmacodynamics

pharmacology

autonomic nervous system

pharmacology

cholinergic agonist

pharmacology

Research ethics and clinical trials in therapeutic research

Pharmacy ethics

Making ethical decisions

Pharmacy ethics

Inter-professional relationship

Pharmacy ethics

Some ethical considerations

Pharmacy ethics

Urinary Tract Infections

Clinical pharmacy

الأخبار والإعلانات

1
الأخبار 2020-11-05

مناقشة رسالة الماجستير بعنوان (تأثير كل من البربرين ،المايرستين والجمع بينهما في الحماية من ألاصابة بنقص التروية الدماغية وأعادة التروية في الجرذان ودور مستقبلات النوتج في هذه التأثيرات) وذلك يوم الثلاثاء المصادف 24/12/2019

عرض التفاصيل